BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pose E, Solà E, Lozano JJ, Juanola A, Sidorova J, Zaccherini G, de Wit K, Uschner F, Tonon M, Kazankov K, Jiménez C, Campion D, Napoleone L, Ma AT, Carol M, Morales-Ruiz M, Alessandria C, Beuers U, Caraceni P, Francoz C, Durand F, Mookerjee RP, Trebicka J, Vargas V, Piano S, Watson H, Abraldes JG, Kamath PS, Davis MM, Ginès P; investigators of the LIVERHOPE Consortium. Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis. Hepatol Commun 2021. [PMID: 34964311 DOI: 10.1002/hep4.1881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu G, Wang X, Fan X, Luo X. Metabolomics profiles in acute-on-chronic liver failure: Unveiling pathogenesis and predicting progression. Front Pharmacol 2022;13:953297. [DOI: 10.3389/fphar.2022.953297] [Reference Citation Analysis]
2 Moctezuma-velazquez C, Abraldes JG. The Role of Statins in Cirrhosis. Curr Treat Options Gastro 2022;20:316-335. [DOI: 10.1007/s11938-022-00394-x] [Reference Citation Analysis]
3 Graupera I, Isus L, Coll M, Pose E, Díaz A, Vallverdú J, Rubio-tomás T, Martínez-sánchez C, Huelin P, Llopis M, Solé C, Fondevila C, Lozano JJ, Sancho-bru P, Ginès P, Aloy P. Molecular characterization of chronic liver disease dynamics: from liver fibrosis to acute-on-chronic liver failure. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100482] [Reference Citation Analysis]